Trial Profile
An Open-label, PRospective Study to Evaluate Social Function and Overall Improvement of Paliperidone ER Treatment in Thai Schizophrenia PatieNT (PRESENT).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Mar 2013
Price :
$35
*
At a glance
- Drugs Paliperidone (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- Acronyms PRESENT
- Sponsors Janssen-Cilag
- 04 Mar 2013 Actual initiation date changed from Jul 2009 to Aug 2009 as reported by ClinicalTrials.gov.
- 06 Jul 2011 New trial record